Add to ORKGIn this short paper we present preliminary results on computing, in silico, personalised therapies for Colorectal Cancer (CRC), one of the deadliest form of tumour for adult humans. We exploit a recent SBML (Systems Biology Markup Language) model of the tumour growth, which also models the PharmacoKinetics/Pharmacodynamics (PK/PD) of two immunotherapic drugs that may be used in combination treatments
AbstractColon and Colorectal cancer are a diagnosis of particular concern for older Canadians. They ...
It is widely accepted that the design of a novel drug is a challenging, time-consuming and very expe...
Current colorectal cancer (CRC) treatment guidelines are primarily based on clinical features, such ...
450,000 European citizens are diagnosed every year with colorectal cancer (CRC) and more than 230,00...
CRC is one of the deadliest forms of tumor for adult humans, which often requires expensive and high...
Solid tumors are rich ecosystems of numerous different cell types whose interactions lead to immune ...
Colorectal cancer (CRC) is the third most common cancer in the UK, with over 37,500 people being dia...
Understanding the cancer pathology and develop effective treatment strategies play significant roles...
Abstract: Understanding and improving the effects of combined drug treatments in metastatic colorect...
International audienceUnderstanding and improving the effects of combined drug treatments in metastat...
Colorectal cancer has formed a canonical example of tumourigenesis ever since its use in Fearon and ...
In this paper, we have used an agent-based stochastic tumor growth model and presented a mathematica...
Mathematical modeling and computer simulations were used to study the dynamics of cancer immunothera...
To improve and focus preclinical testing, we combine tumor models based on a decellularized tissue m...
Cancer is a heterogeneous and complex disease and one of the leading causes of death worldwide. The ...
AbstractColon and Colorectal cancer are a diagnosis of particular concern for older Canadians. They ...
It is widely accepted that the design of a novel drug is a challenging, time-consuming and very expe...
Current colorectal cancer (CRC) treatment guidelines are primarily based on clinical features, such ...
450,000 European citizens are diagnosed every year with colorectal cancer (CRC) and more than 230,00...
CRC is one of the deadliest forms of tumor for adult humans, which often requires expensive and high...
Solid tumors are rich ecosystems of numerous different cell types whose interactions lead to immune ...
Colorectal cancer (CRC) is the third most common cancer in the UK, with over 37,500 people being dia...
Understanding the cancer pathology and develop effective treatment strategies play significant roles...
Abstract: Understanding and improving the effects of combined drug treatments in metastatic colorect...
International audienceUnderstanding and improving the effects of combined drug treatments in metastat...
Colorectal cancer has formed a canonical example of tumourigenesis ever since its use in Fearon and ...
In this paper, we have used an agent-based stochastic tumor growth model and presented a mathematica...
Mathematical modeling and computer simulations were used to study the dynamics of cancer immunothera...
To improve and focus preclinical testing, we combine tumor models based on a decellularized tissue m...
Cancer is a heterogeneous and complex disease and one of the leading causes of death worldwide. The ...
AbstractColon and Colorectal cancer are a diagnosis of particular concern for older Canadians. They ...
It is widely accepted that the design of a novel drug is a challenging, time-consuming and very expe...
Current colorectal cancer (CRC) treatment guidelines are primarily based on clinical features, such ...